InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,184.19
(
0.07%
)
US TECH 100
17,590.20
(
-0.11%
)
Dow Jones
38,868.29
(
0.04%
)
Brent Oil
83.14
(
-0.41%
)
Bitcoin
63,038.24
(
-0.20%
)
Post# of 458486
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

boi568

Send PM Follow Ignore
Followers 50
Posts 5379
Boards Moderated 0
Alias Born 07/03/2020

boi568

Re: BIOChecker4 post# 277773

Wednesday, 10/21/2020 4:39:26 PM

Wednesday, October 21, 2020 4:39:26 PM

Post# of 458486
Phase 3 after Phase 2's more often fail for safety or commercial concerns than efficacy. Average approval rate is 59 percent with all risk factors. 2-73 is relatively low risk for Phase 3 failure compared to the rest. Depends what you call high risk.
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News
InvestorsHub NewsWire

FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM

Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Start posting your company's news
Only $200 per official company press release!